Autumn Galbraith
Reproductive Endocrinology · Knoxville, TNNPI 1265730337
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations.
Across 248 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$675
- Sage Therapeutics, LLC$670
- AbbVie$570
- Astellas Pharma US Inc$277
- Sumitomo Pharma America, Inc.$271
- Daiichi Sankyo Inc.$265
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,374100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 33 | $675 |
| Sage Therapeutics, LLC | 42 | $670 |
| AbbVie | 40 | $570 |
| Astellas Pharma US Inc | 8 | $277 |
| Sumitomo Pharma America, Inc. | 13 | $271 |
| Daiichi Sankyo Inc. | 16 | $265 |
| Myovant Sciences Inc. | 14 | $198 |
| Therapeuticsmd, Inc. | 10 | $134 |
| Organon | 6 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $126 |
| Millicent US Inc | 6 | $122 |
| Pfizer | 6 | $112 |
| Supernus Pharmaceuticals, Inc. | 6 | $104 |
| Aspira Women's Health Inc | 2 | $104 |
| Novo Nordisk | 6 | $96 |
| Boston Scientific | 4 | $82 |
| Exeltis, USA Inc. | 5 | $70 |
| Lilly USA, LLC | 4 | $66 |
| Avion Pharmaceuticals | 4 | $57 |
| Scynexis, Inc. | 3 | $42 |
| Hologic Sales And Service, LLC | 2 | $37 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Agile Therapeutics, Inc. | 2 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| BD | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIJUVA$125
- Veozah$125
- NEXTSTELLIS$124
How this compares
$4,374 in reported general payments places this provider in the 85th percentile of 23 reproductive endocrinology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other reproductive endocrinology in Knoxville
- John GordonKnoxville$535
- Jeffrey KeenanKnoxville$369
- Gayla HarrisKnoxville$13
- Amelia BaileyMemphis$206K
- William KuttehMemphis$70K
- George HillNashville$7K
- Glenn WeitzmanNashville$3K
- Paul BrezinaMemphis$2K
- Christopher MontvilleFranklin$2K
- Kristin van HeertumNashville$920
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.